Rare Diseases Symptoms Automatic Extraction
Home
A random Abstract
Our Project
Our Team
Role of imatinib in the treatment of pediatric onset indolent systemic mastocytosis: a case report.
[cutaneous mastocytosis]
Mastocytosis
is
a
sporadic
disease
characterized
by
an
abnormal
accumulation
of
mast
cells
(
MCs
)
in
single
or
multiple
organs
.
It
has
a
heterogeneous
clinical
picture
which
is
a
reflection
of
underlying
tissue
MC
burden
,
mediators
released
and
the
organs
involved
.
Here
,
the
authors
report
significant
symptomatic
,
cutaneous
and
systemic
response
to
imatinib
in
a
case
of
childhood
onset
indolent
D
816
V
KIT
unmutated
systemic
mastocytosis
(
SM
)
.
A
19
-
year
-old
female
presented
with
a
history
of
itchy
skin
lesions
over
the
face
,
trunk
and
extremities
since
6
months
of
age
associated
with
recurrent
bouts
of
angioedema
.
The
skin
and
bone
marrow
examination
were
consistent
with
mastocytosis
.
No
pathogenic
mutations
were
detected
in
exons
8
and
17
.
In
view
of
the
severity
of
cutaneous
symptoms
and
evidence
of
bone
marrow
involvement
,
she
was
treated
with
imatinib
which
resulted
in
marked
improvement
.
Imatinib
has
a
therapeutic
role
in
the
presence
of
an
imatinib-sensitive
KIT
mutation
or
in
KIT
816
-
unmutated
patients
with
aggressive
SM
.
Its
role
in
the
treatment
of
indolent
and
cutaneous
mastocytosis
is
less
well
established
.
However
,
the
authors
have
demonstrated
the
usefulness
of
imatinib
in
the
treatment
of
c-
KIT
-negative
indolent
SM
with
extensive
cutaneous
involvement
.
Diseases
Validation
Diseases presenting
"bone marrow examination"
symptom
cohen syndrome
cutaneous mastocytosis
erythropoietic protoporphyria
oculocutaneous albinism
sneddon syndrome
waldenström macroglobulinemia
You can validate or delete this automatically detected symptom
Validate the Symptom
Delete the Symptom